Definitive Contract 75N95026C00008
- Not listed
- The National Institute on Drug Abuse awarded a cost-plus-no-fee definitive contract to Greater Los Angeles Veterans Research and Education Foundation (GLAVREF) for the NIH Neurobank Brain and Tissue Repository program. The contract, valued at approximately $12.8 million, commenced on September 1, 2019, with an ultimate completion date of October 31, 2025. No set-aside designation was utilized for this award, indicating the contract was competed based on scientific and technical merit. GLAVREF, a...
- The National Institute on Drug Abuse awarded a definitive contract valued at $18.5 million to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish and operate the NIH NeuroBank Brain and Tissue Repository (NBB), a collection site dedicated to acquiring, processing, storing, curating, preserving, and distributing central nervous system and related tissues for research purposes. This cost-plus-no-fee contract, which commenced on November 1, 2025, and extends through October 31, 2030,...
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to the University of Miami to establish a collection site (the NIH Brain and Tissue Repository) that will actively acquire, receive, store, curate, preserve, and distribute central nervous system and related biological specimens for research on neurological, psychiatric, and neurodevelopmental disorders. The $25,542,514.53 contract is for a definitive, cost-no-fee...
- This is a $220,000.00 fixed-price level of effort purchase order contract awarded by the Defense Health Agency (DHA) to the Greater Los Angeles Veterans Research And Education Foundation (GLAVREF), a non-profit organization. The contract is for immunohistochemistry and analysis services, including research and reporting on immunohistochemical slide tissue scans of brain matter. The contract has an ultimate completion date of November 23, 2026 and was awarded on July 24, 2024. GLAVREF is a...
- <p>This is a $1,433,356.00 firm fixed price definitive contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to The Brain Donor Project, a non-profit organization located in Naples, Florida. The contract is for NEUROBIOBANK (NBB) communications and outreach services from September 30, 2022 to September 29, 2026, with a potential completion date of September 29, 2027. The contract does not have a set-aside designation.</p>
- This is a $15,570,163.30 definitive contract awarded by the National Institute on Drug Abuse (part of the National Institutes of Health) to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish a collection site for the NIH Brain and Tissue Repository (NBTR). The purpose is to acquire, receive, process, store, curate, preserve, and distribute central nervous system and related biological samples to support research on neurological, psychiatric, and neurodevelopmental disorders. The...
- The National Institute of Mental Health awarded a $11.1 million definitive contract to the University of California, Los Angeles (UCLA) to serve as a clinical site for the National NeuroHIV Tissue Consortium (NNTC). Under this cost-plus-no-fee contract, UCLA will collect, store, and provide clinical data and well-characterized biological specimens, including post-mortem tissue from study volunteers and organ donors with HIV as well as HIV-negative controls. The contract, which commenced on...
- This federal contract was awarded by the National Institutes of Health (NIH) to the University of Maryland, Baltimore (UMB) to administer the NIH NeuroBioBank and Tissue Repository. The purpose is to increase the availability of human brain tissue samples for research on neurological, psychiatric, and neurodevelopmental disorders. The contract has a ceiling value of $23,683,813.78 and was awarded on a cost-no-fee basis with an ultimate completion date of October 31, 2025. It is not a set-aside...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to the National Disease Research Interchange (NDRI), a Philadelphia-based non-profit organization, for brain pathology and transport services. The $199,077.98 firm-fixed-price purchase order has an ultimate completion date of December 19, 2025. NDRI, which does business as the Human Biological Data Interchange, provides specialized human tissue procurement, pathology, and transportation services to support...
- This is a definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to the Coriell Institute for Medical Research, Inc., a non-profit biomedical research center. The contract, valued at $12,298,175.00, is for the operation of the NINDS Human Genetics Resource Center, which maintains a collection of over 1.9 million biological samples from 52,000 individuals to support research into the genetic causes of neurological disorders. The...
The National Institute on Drug Abuse awarded a $17.7M definitive contract to the Greater Los Angeles Veterans Research and Education Foundation (GLAVREF) to establish and operate a collection site for the NIH Neurobiobank Brain and Tissue Repository. Under this cost-no-fee contract, GLAVREF will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system and related tissue specimens from deceased donors to support neurological, psychiatric, and neurodevelopmental disorder research. The contract runs through October 31, 2030, with performance based at the Veterans Administration facility in Los Angeles, California. GLAVREF will be responsible for acquiring brain tissue from diverse donor populations, including individuals with and without known neurological disorders, and must maintain detailed inventory documentation through the NIH NeuroBioBank Portal while adhering to tissue-sharing guidelines established by the NIH. This award was issued through full and open competition under solicitation 75N95024R00124, which sought multiple contractors to serve as regional collection sites for the broader NIH NeuroBioBank initiative. The opportunity required offerors to demonstrate capacity to acquire at least 70 donors annually, with potential to process up to 150 unique donors per year over the five-year performance period. GLAVREF's selection reflects its demonstrated expertise in medical research and tissue analysis, as evidenced by prior federal contract awards involving immunohistochemistry services and neurological research, as well as its collaborative relationships with prominent academic medical institutions. The contract represents a no-set-aside award based on scientific merit and organizational capability.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $1.9m | 12/4/25 |